The Belt and Road: Cooperation, Harmony and Win-Win
products

Products

Solifenacin succinate CAS:242478-38-2

Solifenacin succinate is a medication used to treat overactive bladder (OAB) symptoms such as urinary frequency, urgency, and incontinence. It belongs to a class of drugs called antimuscarinics, which work by relaxing the bladder muscles and reducing inappropriate contractions. Solifenacin succinate is available in tablet form and is typically taken orally.


Product Detail

Product Tags

Application and Effect:

Solifenacin succinate is widely utilized in the management of overactive bladder, a condition characterized by an uncontrollable urge to urinate and often accompanied by frequent urination and nocturia. By blocking specific receptors in the bladder muscles that control contractions, solifenacin succinate helps to increase bladder capacity and reduce involuntary spasms, leading to improved urinary control and decreased urgency episodes. This medication is prescribed to individuals who experience bothersome OAB symptoms that significantly impact their quality of life and daily activities. Solifenacin succinate provides relief from urinary urgency and frequency, allowing patients to regain control over their bladder function and reduce the risk of embarrassing or inconvenient episodes of urinary incontinence. Moreover, solifenacin succinate offers benefits beyond symptom relief, including enhancement of patient comfort and confidence in social situations. By addressing the underlying muscle dysfunction associated with OAB, it aids in restoring normal voiding patterns and minimizing the disruptive effects of bladder overactivity on physical and emotional well-being. In addition, solifenacin succinate plays a role in optimizing treatment outcomes for individuals with neurogenic bladder dysfunction or other conditions that affect bladder control. Its therapeutic effects on bladder muscle function make it a valuable tool in the comprehensive management of urinary symptoms related to neurological disorders or other underlying conditions contributing to OAB. Overall, solifenacin succinate represents a pivotal pharmacological intervention in the treatment of overactive bladder, offering symptomatic relief, improved bladder function, and enhanced quality of life for individuals struggling with the challenges of urinary urgency and incontinence. Its efficacy in addressing OAB symptoms underscores its importance in empowering patients to regain control over their bladder health and enjoy a more comfortable and active lifestyle.

Product Sample:

L-Arginine1
L-Arginine2

Product Packing:

L-Arginin3

Additional Information:

Composition C27H32N2O6
Assay 99%
Appearance white powder
CAS No.  242478-38-2
Packing Small and bulk
Shelf Life 2 years
Storage Store in cool and dry area
Certification ISO.

 


  • Previous:
  • Next:

  • Write your message here and send it to us